Dabigatran etexilate for thromboprophylaxis in over 5000 hip or knee replacement patients in a real-world clinical setting

BACKGROUND: Thromboprophylaxis is recommended for patients undergoing total hip or total knee replacement (THR, TKR). An international, open-label, prospective, observational, single-arm study in a routine clinical setting was performed to assess the safety and efficacy of dabigatran etexilate 220 m...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosencher, Nadia, Samama, Charles M., Feuring, Martin, Brueckmann, Martina, Kleine, Eva, Clemens, Andreas, Frostick, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Original Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818472/
https://www.ncbi.nlm.nih.gov/pubmed/27042163
http://dx.doi.org/10.1186/s12959-016-0082-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818472/
https://www.ncbi.nlm.nih.gov/pubmed/27042163
http://dx.doi.org/10.1186/s12959-016-0082-4

Ejemplares similares